Form D — Ambagon Therapeutics Inc.
0001819934-25-000001 · filed 2025-02-07
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $12,000,000
- Total sold
- $5,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ambagon Therapeutics Inc.
- CIK
- 1819934
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- De Lismortel 31, Catalyst Business Ctr
Eindhoven, P7 5612 AR - Phone
- 31 40 7517694
Related persons
-
Melissa McCracken · DirectorEindhoven, P7
-
Christian Ottmann · Executive OfficerEindhoven, P7
-
Josh Seidenfeld · Executive OfficerPalo Alto, CA
View original on SEC EDGAR.